967
Views
3
CrossRef citations to date
0
Altmetric
Review Articles

Percutaneous gastrostomy in amyotrophic lateral sclerosis: a review

, & ORCID Icon
Pages 176-189 | Received 18 Jan 2021, Accepted 14 Jun 2021, Published online: 01 Jul 2021

References

  • Allen JA, Chen R, Ajroud-Driss S, Sufit RL, Heller S, Siddique T, et al. Gastrostomy tube placement by endoscopy versus radiologic methods in patients with ALS: a retrospective study of complications and outcome. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:308–14.
  • Pena MJ, Ravasco P, MacHado M, Pinto A, Pinto S, Rocha L, et al. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012;13:550–4.
  • Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–72.
  • Cui F, Sun L, Xiong J, Li J, Zhao Y, Huang X. Therapeutic effects of percutaneous endoscopic gastrostomy on survival in patients with amyotrophic lateral sclerosis: a meta-analysis. PLoS One. 2018;13:e0192243.
  • Chen X, Wei QQ, Chen Y, Cao B, Ou RW, Hou Y, et al. Clinical staging of amyotrophic lateral sclerosis in Chinese patients. Front Neurol. 2018;9:442.
  • Kirstein MM, Körner S, Schneider A, Manns MP, Petri S, Voigtländer T. Percutaneous endoscopic gastrostomy with and without jejunal extension in patients with amyotrophic lateral sclerosis. Eur J Gastroenterol Hepatol. 2018;30:257–62.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Lou JS, Moore D, Gordon PH, Miller R. Correlates of quality of life in ALS: lessons from the minocycline study. Amyotroph Lateral Scler. 2010;11:116–21.
  • McDermott CJ. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol. 2015;14:702–9.
  • Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract. 2013;28:392–9.
  • Bond L, Ganguly P, Khamankar N, Mallet N, Bowen G, Green B, et al. A comprehensive examination of percutaneous endoscopic gastrostomy and its association with amyotrophic lateral sclerosis patient outcomes. Brain Sci. 2019;9:223.
  • Bokuda K, Shimizu T, Imamura K, Kawata A, Watabe K, Hayashi M, et al. Predictive factors for prognosis following unsedated percutaneous endoscopic gastrostomy in ALS patients. Muscle Nerve. 2016;54:277–83.
  • Dorst J, Dupuis L, Petri S, Kollewe K, Abdulla S, Wolf J, et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study. J Neurol. 2015;262:849–58.
  • Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82:628–34.
  • Rahnemai-azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT, Rahnemai-azar AA, et al. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20:7739–51.
  • Stavroulakis T, Walsh T, Shaw PJ, McDermott CJ, Progas Study. Gastrostomy use in motor neurone disease (MND): a review, meta-analysis and survey of current practice. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:96–104.
  • Strong MJ, Rowe A, Rankin RN. Percutaneous gastrojejunostomy in amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:128–32.
  • Kurien M, Mcalindon ME, Westaby D, Sanders DS, Sheffield S. Percutaneous endoscopic gastrostomy (PEG) feeding. BMJ. 2010;340:c2414–6.
  • Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2011;11:CD004030.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–94.
  • Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney de Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc. 1994;40:463–9.
  • Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242:695–8.
  • Chiò A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. Neurology 1999;53:1123–5.
  • Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci. 1999;169:118–25.
  • Forbes RB, Colville S, Swingler RJ, Scottish Motor Neurone Disease Research GroupFrequency Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease-a record linkage study from the Scottish Motor Neurone Disease Register . J Neurol. 2004;251:813–7.
  • Desport J, Mabrouk T, Bouillet P, Perna A, Preux P, Couratier P. Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2005;6:88–93.
  • Limousin N, Blasco H, Corcia P, Gordon PH, De Toffol B, Andres C, et al. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS. J Neurol Sci. 2010;297:36–9.
  • Rio A, Ellis C, Shaw C, Willey E, Ampong MA, Wijesekera L, et al. Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease. J Hum Nutr Diet. 2010;23:408–15.
  • Atassi N, Cudkowicz ME, Schoenfeld DA. Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:272–7.
  • Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304:44–8.
  • Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLoS One. 2017;12:e0177555.
  • Fasano A, Fini N, Ferraro D, Ferri L, Vinceti M, Mandrioli J. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:233–42.
  • Lavernhe S, Antoine JC, Court-Fortune I, Dimier N, Costes F, Lacour A, et al. Home care organization impacts patient management and survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:562–8.
  • Nagashima K, Furuta N, Makioka K, Fujita Y, Ikeda M, Ikeda Y. An analysis of prognostic factors after percutaneous endoscopic gastrostomy placement in Japanese patients with amyotrophic lateral sclerosis. J Neurol Sci. 2017;376:202–5.
  • Thompson AG, Blackwell V, Marsden R, Millard E, Lawson C, Nickol AH, et al. A risk stratifying tool to facilitate safe late-stage percutaneous endoscopic gastrostomy in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:243–8.
  • Carbó Perseguer J, Madejón Seiz A, Romero Portales M, Martínez Hernández J, Mora Pardina JS, García-Samaniego J. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis: mortality and complications. Neurologia (Engl Ed). 2019;34:582–8.
  • Barone M, Viggiani MT, Introna A, D’errico E, Scarafino A, Iannone A, et al. Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement. Amyotroph Lateral Scler Front Degener. 2019;20:490–6.
  • Elbe P, Markus K, Valente R, Ingre C, Apostolos V, Tsolakis MV. Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis. Minerva Gastroenterol Dietol. 2020;66:219–24.
  • Hesters A, Amador M del M, Debs R, Le Forestier N, Lenglet T, Pradat PF, et al. Predictive factors for prognosis after gastrostomy placement in routine non-invasive ventilation users ALS patients. Sci Rep. 2020;10:1–6.
  • Kim EY, Kang SW, Suh MR, Jung J, Park J, Choi WA. Safety of gastrostomy tube placement in patients with advanced amyotrophic lateral sclerosis with noninvasive ventilation. J Parenter Enter Nutr. 2020.
  • Vergonjeanne M, Fayemendy P, Marin B, Penoty M, Lautrette G, Sourisseau H, et al. Predictive factors for gastrostomy at time of diagnosis and impact on survival in patients with amyotrophic lateral sclerosis. Clin Nutr. 2020;39:3112–8.
  • Strijbos D, Hofstede J, Keszthelyi D, Masclee AAM, Gilissen LPL. Percutaneous endoscopic gastrostomy under conscious sedation in patients with amyotrophic lateral sclerosis is safe: an observational study. Eur J Gastroenterol Hepatol. 2017;29:1303–8.
  • Jean CD, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler. 2000;1:91–6.
  • Mitsumoto H, Davidson M, Moore D, Gad N, Brandis M, Ringel S, the ALS CARE Study Group, et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Mot Neuron Disord. 2003;4:177–85.
  • Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Eurals Consortium, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Blasco H, Patin F, Molinier S, Vourc'h P, Le Tilly O, Bakkouche S, et al. A decrease in blood cholesterol after gastrostomy could impact survival in ALS. Eur J Clin Nutr. 2017;71:1133–5.
  • De Carvalho M, Swash M, Pinto S. Diaphragmatic neurophysiology and respiratory markers in ALS. Front Neurol. 2019;10:143.
  • Manera U, Torrieri MC, Moglia C, Viglione M, Daviddi MAR, Matteoni E, et al. The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring. J Neurol Neurosurg Psychiatry. 2020;91:999–1000.
  • Yang B, Shi X. Percutaneous endoscopic gastrostomy versus fluoroscopic gastrostomy in amyotrophic lateral sclerosis (ALS) sufferers with nutritional impairment: a meta-analysis of current studies. Oncotarget 2017;8:102244–53.
  • Yuan TW, He Y, Wang SB, Kong P, Cao J. Technical success rate and safety of radiologically inserted gastrostomy versus percutaneous endoscopic gastrostomy in motor neuron disease patients undergoing: a systematic review and meta-analysis. J Neurol Sci. 2020;410:116622.
  • Scott A. G, Austin HE. Nasogastric feeding in the management of severe dysphagia in motor neurone disease. Palliat Med. 1994;8:45–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.